YY1 and Familial prostate cancer: With respect to clinical prognosis, it is interesting to note that lower expression of nuclear YY1 correlates with a poorer outcome for prostate cancer [30], with the data suggesting that decreased YY1 levels give metastatic cells a survival advantage.